BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9618113)

  • 1. Subsegmental transcatheter arterial embolization for hepatocellular carcinoma in the caudate lobe.
    Terayama N; Miyayama S; Tatsu H; Yamamoto T; Toya D; Tanaka N; Mitsui T; Miura S; Fujisawa M; Kifune K; Matsui O; Takashima T
    J Vasc Interv Radiol; 1998; 9(3):501-8. PubMed ID: 9618113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
    Nishimine K; Uchida H; Matsuo N; Sakaguchi H; Hirohashi S; Nishimura Y; Guo Q; Ohishi H; Nagano N; Yoshioka T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S60-8. PubMed ID: 7511069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization.
    Matsui O; Kadoya M; Yoshikawa J; Gabata T; Arai K; Demachi H; Miyayama S; Takashima T; Unoura M; Kogayashi K
    Radiology; 1993 Jul; 188(1):79-83. PubMed ID: 8390073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective segmental chemoembolization of advanced hepatocellular carcinoma with tumor thrombus in the portal vein.
    Katsumori T; Fujita M; Takahashi T; Satoh O; Ichijima S; Nakamura T; Morishita H; Ohno K; Nakano Y; Maeda T
    Cardiovasc Intervent Radiol; 1995; 18(4):217-21. PubMed ID: 8581900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left lobe recurrent hepatocellular carcinoma treated with lipiodol-TAE via the left internal mammary artery.
    Kanetsuki I; Hori A; Ohshiro K; Nishi H; Yasutani T; Sueyoshi T; Tanaka H
    Cardiovasc Intervent Radiol; 1997; 20(5):387-9. PubMed ID: 9271652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role.
    Chung JW; Park JH; Han JK; Choi BI; Kim TK; Han MC
    J Vasc Interv Radiol; 1998; 9(3):495-500. PubMed ID: 9618112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transarterial chemoembolization (TAE) with degradable starch microspheres (DSM) in advanced hepatocellular carcinoma].
    Horikiri N; Yamakado K; Nakatsuka A; Ishii T; Matsushima N; Tanaka N; Takeda K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1493-6. PubMed ID: 11707962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.
    Higuchi T; Kikuchi M; Okazaki M
    Cancer; 1994 May; 73(9):2259-67. PubMed ID: 7513245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization.
    Tanaka K; Nakamura S; Numata K; Okazaki H; Endo O; Inoue S; Takamura Y; Sugiyama M; Ohaki Y
    Radiology; 1992 Nov; 185(2):457-60. PubMed ID: 1329143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization (TAE)--significance of repetitive therapies and responses to them within 6 months after the first intervention].
    Kantoh T; Abo H; Tomotsu K; Usui T
    Nihon Shokakibyo Gakkai Zasshi; 1993 May; 90(5):1416-24. PubMed ID: 8391602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
    Hirashima N; Sakakibara K; Itazu I; Hirai T; Nemoto A; Matsuura H; Kumada K; Nojiri O; Kano H
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma and transcatheter oily chemoembolization in Thailand.
    Phornphutkul K; Handagoon P; Sirivanichai C; Senarat S; Nakamura H
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1239-46. PubMed ID: 1325144
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of hepatocellular carcinoma by chemoembolization].
    Marchiori L; Mansueto GC; Nifosi F; Bortolasi L; Dal Dosso I; Facci E; Perus G; Nicoli N
    Chir Ital; 1994; 46(1):17-22. PubMed ID: 8025966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence.
    Murakami R; Yoshimatsu S; Yamashita Y; Sagara K; Arakawa A; Takahashi M
    Acta Radiol; 1994 Nov; 35(6):576-80. PubMed ID: 7946681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caudate lobe hepatocellular carcinoma treated with selective chemoembolization.
    Kim HC; Chung JW; Jae HJ; Yoon JH; Lee JH; Kim YJ; Lee HS; Yoon CJ; Park JH
    Radiology; 2010 Oct; 257(1):278-87. PubMed ID: 20697120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial embolization of the internal mammary artery in hepatocellular carcinoma.
    Kim JH; Chung JW; Han JK; Park JH; Choi BI; Han MC
    J Vasc Interv Radiol; 1995; 6(1):71-4; discussion 75-7. PubMed ID: 7703585
    [No Abstract]   [Full Text] [Related]  

  • 19. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management.
    Hatanaka Y; Yamashita Y; Takahashi M; Koga Y; Saito R; Nakashima K; Urata J; Miyao M
    Radiology; 1995 Jun; 195(3):747-52. PubMed ID: 7754005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of segmental Lp-TAE using lipiodol mixed with anticancer agent for inoperable hepatocellular carcinoma].
    Matsuo N; Nishimine K; Uchida H; Nagano N; Nishimura Y; Oiyong G; Sakaguchi H; Yoshioka T; Ohue S; Ohishi H
    Nihon Shokakibyo Gakkai Zasshi; 1992 Jul; 89(7):1415-24. PubMed ID: 1325006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.